← Back to Search

Other

Group A: Cream of formulation A for Dry Skin (COS-PBP-01 Trial)

N/A
Recruiting
Led By Samuel Fortin, Ph.D
Research Sponsored by SCF Pharma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant aged between 18 and 65 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

COS-PBP-01 Trial Summary

This trial aims to test a 14-day hydrating treatment on dry skin. Thirty-three subjects will be divided into three groups and receive different creams, but the same serum. The effects of the treatment

Who is the study for?
This trial is for individuals aged 18-65 with dry skin who can commit to the study's duration. They must be able to understand and follow instructions without intellectual impairments that affect consent or protocol adherence. Those with a diagnosed skin disease requiring medication cannot participate.Check my eligibility
What is being tested?
The study tests three different Glyceryl Eicosapentaenoate-based creams (A, B, C) and one serum for hydrating sensitive, dry skin over 14 days. Thirty-three participants will be divided into groups of eleven to receive one cream type each along with the same serum.See study design
What are the potential side effects?
Potential side effects may include irritation or allergic reactions at the application site due to ingredients in the creams or serum. However, these products are designed to minimize irritants for sensitive skin.

COS-PBP-01 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

COS-PBP-01 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure of Hydration
Measure of skin redness
Secondary outcome measures
Control of skin appearance and adverse events

COS-PBP-01 Trial Design

3Treatment groups
Experimental Treatment
Group I: Group C: Cream of formulation CExperimental Treatment2 Interventions
Daily application of glyceryl Eicosapentaenoate serum and glyceryl Eicosapentaenoate cream of formulation C on both targeted skin area. The skin areas must be clean and dry. Subjects may proceed with additional product applications if needed. However, for each additional application, both targeted areas must be treated with the Serum and the cream. Subjects must proceed with at least one application of products each day for 14 consecutive days.
Group II: Group B: Cream of formulation BExperimental Treatment2 Interventions
Daily application of glyceryl Eicosapentaenoate serum and glyceryl Eicosapentaenoate cream of formulation B on both targeted skin area. The skin areas must be clean and dry. Subjects may proceed with additional product applications if needed. However, for each additional application, both targeted areas must be treated with the Serum and the cream. Subjects must proceed with at least one application of products each day for 14 consecutive days.
Group III: Group A: Cream of formulation AExperimental Treatment2 Interventions
Daily application of glyceryl Eicosapentaenoate serum and glyceryl Eicosapentaenoate cream of formulation A on both targeted skin area. The skin areas must be clean and dry. Subjects may proceed with additional product applications if needed. However, for each additional application, both targeted areas must be treated with the Serum and the cream. Subjects must proceed with at least one application of products each day for 14 consecutive days.

Find a Location

Who is running the clinical trial?

Institut de recherche clinique du littoral (IRCL)UNKNOWN
1 Previous Clinical Trials
16 Total Patients Enrolled
SCF PharmaLead Sponsor
6 Previous Clinical Trials
309 Total Patients Enrolled
Samuel Fortin, Ph.DPrincipal InvestigatorSCF Pharma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria should be considered when selecting participants for this clinical trial?

"To be eligible for this investigation, patients must exhibit symptoms of dry skin and fall within the age range of 18 to 65 years old. The trial aims to recruit approximately 33 participants."

Answered by AI

Are new patients currently being enrolled in this ongoing clinical trial?

"Indeed, the information available on clinicaltrials.gov verifies that this particular clinical trial is actively seeking participants. The study was initially posted on July 25th, 2023 and last updated on January 22nd, 2024. It aims to enroll a total of 33 patients from a single designated location."

Answered by AI

What is the total number of subjects actively involved in this research investigation?

"Indeed, the information displayed on clinicaltrials.gov confirms that the trial is presently accepting participants. The study was initially posted on July 25th, 2023 and underwent its most recent update on January 22nd, 2024. A total of 33 individuals will be enrolled at a single site."

Answered by AI

Are individuals aged 25 and above eligible to participate in this medical study?

"To be eligible for participation in this research, individuals must be of legal age (18 years or older) and below 65 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Glyceryl Eicosapentaenoate Based Topic Products as an Irritant-free Cream and Serum for Hydration of Sensitive Skin
2023. "Glyceryl Eicosapentaenoate Based Topic Products as an Irritant-free Cream and Serum for Hydration of Sensitive Skin". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06219213.
~6 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top